DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Linrodostat

Generic Name: Linrodostat

Drug Type: Small Molecule

Chemical Formula: C_₂₄H_₂₄ClFN_₂O

CAS Number: 1923833-60-6

Unique Ingredient Identifier: 0A7729F42K

Overview

Linrodostat is under investigation in clinical trial NCT03247283 (Pharmacokinetics and Metabolism Study in Healthy Male Participants).

Background

Linrodostat is under investigation in clinical trial NCT03247283 (Pharmacokinetics and Metabolism Study in Healthy Male Participants).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma

Phase 2

Withdrawn

Posted: 2019/07/05

Sponsor:Dana-Farber Cancer I...

A Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of BMS-986205 in Healthy Participants

Phase 1

Completed

Posted: 2019/05/03

Sponsor:Bristol-Myers Squibb

A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors

Phase 1

Completed

Posted: 2019/01/03

Sponsor:Bristol-Myers Squibb

A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder

Phase 2

Terminated

Posted: 2018/05/08

Sponsor:Bristol-Myers Squibb

An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread

Phase 1

Completed

Posted: 2018/03/08

Sponsor:Bristol-Myers Squibb

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy